Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued to investors on Monday. The firm set a “sell” rating on the stock.

Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.

Streamline Health Solutions Price Performance

Shares of STRM stock opened at $3.40 on Monday. The business has a fifty day simple moving average of $2.71 and a 200 day simple moving average of $5.43. The company has a market cap of $14.35 million, a P/E ratio of -0.69 and a beta of 1.64. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 0.66. Streamline Health Solutions has a twelve month low of $1.85 and a twelve month high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last posted its earnings results on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). The company had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.